High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer

Heat-shock factor 1 (HSF1) is the master transcriptional regulator of the cellular response to heat and a wide variety of other stressors. We previously reported that HSF1 promotes the survival and proliferation of malignant cells. At this time, however, the clinical and prognostic significance of H...

Full description

Bibliographic Details
Main Authors: Santagata, Sandro, Mendillo, Marc L., Whitesell, Luke, Lindquist, Susan, Hu, Rong, Lin, Nancy U., Collins, Laura C., Hankinson, Susan E., Schnitt, Stuart J., Tamimi, Rulla M., Ince, Tan A.
Other Authors: Massachusetts Institute of Technology. Department of Biology
Format: Article
Language:en_US
Published: National Academy of Sciences 2012
Online Access:http://hdl.handle.net/1721.1/74089
https://orcid.org/0000-0003-1307-882X
_version_ 1826203969340309504
author Santagata, Sandro
Mendillo, Marc L.
Whitesell, Luke
Lindquist, Susan
Hu, Rong
Lin, Nancy U.
Collins, Laura C.
Hankinson, Susan E.
Schnitt, Stuart J.
Tamimi, Rulla M.
Ince, Tan A.
author2 Massachusetts Institute of Technology. Department of Biology
author_facet Massachusetts Institute of Technology. Department of Biology
Santagata, Sandro
Mendillo, Marc L.
Whitesell, Luke
Lindquist, Susan
Hu, Rong
Lin, Nancy U.
Collins, Laura C.
Hankinson, Susan E.
Schnitt, Stuart J.
Tamimi, Rulla M.
Ince, Tan A.
author_sort Santagata, Sandro
collection MIT
description Heat-shock factor 1 (HSF1) is the master transcriptional regulator of the cellular response to heat and a wide variety of other stressors. We previously reported that HSF1 promotes the survival and proliferation of malignant cells. At this time, however, the clinical and prognostic significance of HSF1 in cancer is unknown. To address this issue breast cancer samples from 1,841 participants in the Nurses’ Health Study were scored for levels of nuclear HSF1. Associations of HSF1 status with clinical parameters and survival outcomes were investigated by Kaplan–Meier analysis and Cox proportional hazard models. The associations were further delineated by Kaplan–Meier analysis using publicly available mRNA expression data. Our results show that nuclear HSF1 levels were elevated in ∼80% of in situ and invasive breast carcinomas. In invasive carcinomas, HSF1 expression was associated with high histologic grade, larger tumor size, and nodal involvement at diagnosis (P < 0.0001). By using multivariate analysis to account for the effects of covariates, high HSF1 levels were found to be independently associated with increased mortality (hazards ratio: 1.62; 95% confidence interval: 1.21–2.17; P < 0.0013). This association was seen in the estrogen receptor (ER)-positive population (hazards ratio: 2.10; 95% confidence interval: 1.45–3.03; P < 0.0001). In public expression profiling data, high HSF1 mRNA levels were also associated with an increase in ER-positive breast cancer-specific mortality. We conclude that increased HSF1 is associated with reduced breast cancer survival. The findings indicate that HSF1 should be evaluated prospectively as an independent prognostic indicator in ER-positive breast cancer. HSF1 may ultimately be a useful therapeutic target in cancer.
first_indexed 2024-09-23T12:46:46Z
format Article
id mit-1721.1/74089
institution Massachusetts Institute of Technology
language en_US
last_indexed 2024-09-23T12:46:46Z
publishDate 2012
publisher National Academy of Sciences
record_format dspace
spelling mit-1721.1/740892022-09-28T09:57:51Z High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer Santagata, Sandro Mendillo, Marc L. Whitesell, Luke Lindquist, Susan Hu, Rong Lin, Nancy U. Collins, Laura C. Hankinson, Susan E. Schnitt, Stuart J. Tamimi, Rulla M. Ince, Tan A. Massachusetts Institute of Technology. Department of Biology Whitehead Institute for Biomedical Research Lindquist, Susan Lindquist, Susan Heat-shock factor 1 (HSF1) is the master transcriptional regulator of the cellular response to heat and a wide variety of other stressors. We previously reported that HSF1 promotes the survival and proliferation of malignant cells. At this time, however, the clinical and prognostic significance of HSF1 in cancer is unknown. To address this issue breast cancer samples from 1,841 participants in the Nurses’ Health Study were scored for levels of nuclear HSF1. Associations of HSF1 status with clinical parameters and survival outcomes were investigated by Kaplan–Meier analysis and Cox proportional hazard models. The associations were further delineated by Kaplan–Meier analysis using publicly available mRNA expression data. Our results show that nuclear HSF1 levels were elevated in ∼80% of in situ and invasive breast carcinomas. In invasive carcinomas, HSF1 expression was associated with high histologic grade, larger tumor size, and nodal involvement at diagnosis (P < 0.0001). By using multivariate analysis to account for the effects of covariates, high HSF1 levels were found to be independently associated with increased mortality (hazards ratio: 1.62; 95% confidence interval: 1.21–2.17; P < 0.0013). This association was seen in the estrogen receptor (ER)-positive population (hazards ratio: 2.10; 95% confidence interval: 1.45–3.03; P < 0.0001). In public expression profiling data, high HSF1 mRNA levels were also associated with an increase in ER-positive breast cancer-specific mortality. We conclude that increased HSF1 is associated with reduced breast cancer survival. The findings indicate that HSF1 should be evaluated prospectively as an independent prognostic indicator in ER-positive breast cancer. HSF1 may ultimately be a useful therapeutic target in cancer. National Cancer Institute (U.S.) (Grant R01-CA146445-01) Howard Hughes Medical Institute 2012-10-18T17:51:55Z 2012-10-18T17:51:55Z 2011-09 2011-07 Article http://purl.org/eprint/type/JournalArticle 0027-8424 1091-6490 http://hdl.handle.net/1721.1/74089 Santagata, S. et al. “High Levels of Nuclear Heat-shock Factor 1 (HSF1) Are Associated with Poor Prognosis in Breast Cancer.” Proceedings of the National Academy of Sciences 108.45 (2011): 18378–18383. ©2011 by the National Academy of Sciences https://orcid.org/0000-0003-1307-882X en_US http://dx.doi.org/10.1073/pnas.1115031108 Proceedings of the National Academy of Sciences Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. application/pdf National Academy of Sciences PNAS
spellingShingle Santagata, Sandro
Mendillo, Marc L.
Whitesell, Luke
Lindquist, Susan
Hu, Rong
Lin, Nancy U.
Collins, Laura C.
Hankinson, Susan E.
Schnitt, Stuart J.
Tamimi, Rulla M.
Ince, Tan A.
High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer
title High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer
title_full High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer
title_fullStr High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer
title_full_unstemmed High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer
title_short High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer
title_sort high levels of nuclear heat shock factor 1 hsf1 are associated with poor prognosis in breast cancer
url http://hdl.handle.net/1721.1/74089
https://orcid.org/0000-0003-1307-882X
work_keys_str_mv AT santagatasandro highlevelsofnuclearheatshockfactor1hsf1areassociatedwithpoorprognosisinbreastcancer
AT mendillomarcl highlevelsofnuclearheatshockfactor1hsf1areassociatedwithpoorprognosisinbreastcancer
AT whitesellluke highlevelsofnuclearheatshockfactor1hsf1areassociatedwithpoorprognosisinbreastcancer
AT lindquistsusan highlevelsofnuclearheatshockfactor1hsf1areassociatedwithpoorprognosisinbreastcancer
AT hurong highlevelsofnuclearheatshockfactor1hsf1areassociatedwithpoorprognosisinbreastcancer
AT linnancyu highlevelsofnuclearheatshockfactor1hsf1areassociatedwithpoorprognosisinbreastcancer
AT collinslaurac highlevelsofnuclearheatshockfactor1hsf1areassociatedwithpoorprognosisinbreastcancer
AT hankinsonsusane highlevelsofnuclearheatshockfactor1hsf1areassociatedwithpoorprognosisinbreastcancer
AT schnittstuartj highlevelsofnuclearheatshockfactor1hsf1areassociatedwithpoorprognosisinbreastcancer
AT tamimirullam highlevelsofnuclearheatshockfactor1hsf1areassociatedwithpoorprognosisinbreastcancer
AT incetana highlevelsofnuclearheatshockfactor1hsf1areassociatedwithpoorprognosisinbreastcancer